Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU) Lock-Up Period To Expire on April 22nd

Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU) lock-up period will expire on Tuesday, April 22nd. Oaktree Acquisition Corp. III Life Sciences had issued 17,500,000 shares in its IPO on October 24th. The total size of the offering was $175,000,000 based on an initial share price of $10.00. After the expiration of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Shares of OACCU stock opened at $10.31 on Thursday. Oaktree Acquisition Corp. III Life Sciences has a 1-year low of $9.99 and a 1-year high of $10.60. The stock’s 50 day simple moving average is $10.25.

Hedge Funds Weigh In On Oaktree Acquisition Corp. III Life Sciences

Hedge funds have recently modified their holdings of the business. ADAR1 Capital Management LLC purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $5,065,000. Rangeley Capital LLC purchased a new position in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at $101,000. Athos Capital Ltd purchased a new stake in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth approximately $507,000. Affinity Asset Advisors LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $2,538,000. Finally, Kepos Capital LP purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at $709,000.

About Oaktree Acquisition Corp. III Life Sciences

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.